| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |